English

ATOSSA GENETICS INC

EDGAR

ATOS Quarterly report (10-Q) · filed 2026-08-07

88 filing records in this dataset, filed from 2010-03-30 to 2026-08-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2016 Q3 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

635 thousand USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -4018564 USD Source
Operating Cash Flow: -4654062 USD Source

Cash and cash equivalents: 26.1 million USD 2026-06-30 Source
Exact value

26100000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.98 million shares 2026-06-30 Source
Exact value

9979298 shares

Reported share-count change

-92.27% · -119 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

129171424 shares · 2025-06-30· Source
9979298 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.76 thousand USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Revenue: 1758 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 0 USD · 2015-01-01 – 2015-09-30 Source
Revenue: 0 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 0 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 0 USD · 2016-07-01 – 2016-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-07.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2015-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 9.3 million

Prior period

−USD 25.5 million

2024-01-01 – 2024-12-31
Current period

−USD 34.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-34800000 − -25504000 = -9296000 USD

-25504000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-34800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Year-over-year change in Net income: -9296000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1489938 Filing: 000119312526124396 Input fundies:NetIncome: -25504000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1362231 Filing: 000119312526124396
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 8.77 million

Prior period

−USD 21.03 million

2024-01-01 – 2024-12-31
Current period

−USD 29.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-29800000 − -21030000 = -8770000 USD

-21030000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-29800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Year-over-year change in Operating cash flow: -8770000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -29800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1490477 Filing: 000119312526124396 Input fundies:OperatingCashFlow: -21030000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1414288 Filing: 000119312526124396
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+21.1%

Prior period

USD 19,000

2024-01-01 – 2024-12-31
Current period

USD 23,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

23000 − 19000 = 4000 USD

19000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
23000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Year-over-year change in Capital expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 23000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1421752 Filing: 000119312526124396 Input fundies:CapitalExpenditure: 19000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1423598 Filing: 000119312526124396
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 1,758 100% of revenue
Cost of revenue USD 132,411 7,532% of revenue
Operating expenses USD 12.63 million 718,314% of revenue
Operating income −USD 12.76 million −725,746% of revenue
Tax, interest and other Derived USD 3 million 170,745% of revenue
Net income −USD 15.76 million −896,492% of revenue

Cash

Operating cash flow −USD 13.95 million −793,703% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 725,846% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	1758	12760376 Derived	-12758618	3001705 Derived	-15760323	Unavailable	Source 2015-01-01 – 2015-12-31: 1758 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -12758618 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -15760323 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -13953296 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.8K 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	1758	Revenue: 1758 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 1758 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -725,746.2% 2015

Net margin -896,491.6% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-725,746.2%	Operating Income: -12758618 Open source Revenue: 1758 Open source
20152015-12-31	Net margin	-896,491.6%	Net Income: -15760323 Open source Revenue: 1758 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 1758 Open source Operating Cash Flow: -13953296 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-13953296	Operating Cash Flow: -13953296 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13953296 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

40.1% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	40.1%	Total Liabilities: 2501587 Open source Total Assets: 6243321 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.72× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	1.72×	Current Assets: 4294851 Open source Current Liabilities: 2501587 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 15.76 million Exact value Exact value: -15760323 USD 2015-01-01 – 2015-12-31: -15760323 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2015-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -15760323 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15760323 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577417001151/atos-20161231.xml#94315 Filing: 000161577417001151 The citation records this snapshot. The page link may show a newer release later.	−USD 13.95 million Exact value Exact value: -13953296 USD 2015-01-01 – 2015-12-31: -13953296 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2015-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -13953296 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13953296 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577417001151/atos-20161231.xml#95767 Filing: 000161577417001151 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 6.37 million Exact value Exact value: -6368885 USD 2016-01-01 – 2016-12-31: -6368885 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2016-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -6368885 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6368885 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577418001693/atos-20171231.xml#79037 Filing: 000161577418001693 The citation records this snapshot. The page link may show a newer release later.	−USD 5.37 million Exact value Exact value: -5374589 USD 2016-01-01 – 2016-12-31: -5374589 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2016-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -5374589 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5374589 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577418001693/atos-20171231.xml#80262 Filing: 000161577418001693 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 8.1 million Exact value Exact value: -8100000 USD 2017-01-01 – 2017-12-31: -8100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2017-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -8100000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8100000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577418003668/atos-20180331.xml#41152 Filing: 000161577418003668 The citation records this snapshot. The page link may show a newer release later.	−USD 6.6 million Exact value Exact value: -6600000 USD 2017-01-01 – 2017-12-31: -6600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2017-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -6600000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6600000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000161577418003668/atos-20180331.xml#41649 Filing: 000161577418003668 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 17.83 million Exact value Exact value: -17828000 USD 2020-01-01 – 2020-12-31: -17828000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2020-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -17828000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17828000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774922004614/atos20211231_10k.htm#1285510 Filing: 000143774922004614 The citation records this snapshot. The page link may show a newer release later.	−USD 11.57 million Exact value Exact value: -11570000 USD 2020-01-01 – 2020-12-31: -11570000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2020-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -11570000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11570000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774922004614/atos20211231_10k.htm#987229 Filing: 000143774922004614 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 2020-01-01 – 2020-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2020-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774922004614/atos20211231_10k.htm#990223 Filing: 000143774922004614 The citation records this snapshot. The page link may show a newer release later.	−USD 11.58 million Calculation and evidence -11570000 − 9000 USD Exact free cash flow: -11579000 USD 2020-01-01 – 2020-12-31: -11570000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2020-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -11579000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11570000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774922004614/atos20211231_10k.htm#987229 Filing: 000143774922004614 Input fundies:CapitalExpenditure: 9000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774922004614/atos20211231_10k.htm#990223 Filing: 000143774922004614 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 20.61 million Exact value Exact value: -20606000 USD 2021-01-01 – 2021-12-31: -20606000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2021-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -20606000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20606000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774923007531/atos20221231_10k.htm#1104333 Filing: 000143774923007531 The citation records this snapshot. The page link may show a newer release later.	−USD 16.47 million Exact value Exact value: -16472000 USD 2021-01-01 – 2021-12-31: -16472000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2021-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -16472000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16472000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774923007531/atos20221231_10k.htm#891515 Filing: 000143774923007531 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 2021-01-01 – 2021-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2021-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774923007531/atos20221231_10k.htm#896711 Filing: 000143774923007531 The citation records this snapshot. The page link may show a newer release later.	−USD 16.48 million Calculation and evidence -16472000 − 9000 USD Exact free cash flow: -16481000 USD 2021-01-01 – 2021-12-31: -16472000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2021-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -16481000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16472000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774923007531/atos20221231_10k.htm#891515 Filing: 000143774923007531 Input fundies:CapitalExpenditure: 9000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000143774923007531/atos20221231_10k.htm#896711 Filing: 000143774923007531 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 26.96 million Exact value Exact value: -26960000 USD 2022-01-01 – 2022-12-31: -26960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2022-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -26960000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26960000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017024039306/atos-20231231.htm#1449095 Filing: 000095017024039306 The citation records this snapshot. The page link may show a newer release later.	−USD 20.76 million Exact value Exact value: -20760000 USD 2022-01-01 – 2022-12-31: -20760000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2022-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -20760000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20760000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017024039306/atos-20231231.htm#1490547 Filing: 000095017024039306 The citation records this snapshot. The page link may show a newer release later.	USD 27,000 Exact value Exact value: 27000 USD 2022-01-01 – 2022-12-31: 27000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2022-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 27000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017024039306/atos-20231231.htm#1500391 Filing: 000095017024039306 The citation records this snapshot. The page link may show a newer release later.	−USD 20.79 million Calculation and evidence -20760000 − 27000 USD Exact free cash flow: -20787000 USD 2022-01-01 – 2022-12-31: -20760000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 27000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2022-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -20787000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20760000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017024039306/atos-20231231.htm#1490547 Filing: 000095017024039306 Input fundies:CapitalExpenditure: 27000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017024039306/atos-20231231.htm#1500391 Filing: 000095017024039306 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 30.09 million Exact value Exact value: -30094000 USD 2023-01-01 – 2023-12-31: -30094000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2023-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -30094000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30094000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017025044099/atos-20241231.htm#1233101 Filing: 000095017025044099 The citation records this snapshot. The page link may show a newer release later.	−USD 20.94 million Exact value Exact value: -20941000 USD 2023-01-01 – 2023-12-31: -20941000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2023-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -20941000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20941000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017025044099/atos-20241231.htm#1281507 Filing: 000095017025044099 The citation records this snapshot. The page link may show a newer release later.	USD 14,000 Exact value Exact value: 14000 USD 2023-01-01 – 2023-12-31: 14000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2023-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 14000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017025044099/atos-20241231.htm#1290221 Filing: 000095017025044099 The citation records this snapshot. The page link may show a newer release later.	−USD 20.96 million Calculation and evidence -20941000 − 14000 USD Exact free cash flow: -20955000 USD 2023-01-01 – 2023-12-31: -20941000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 14000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2023-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -20955000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20941000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017025044099/atos-20241231.htm#1281507 Filing: 000095017025044099 Input fundies:CapitalExpenditure: 14000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000095017025044099/atos-20241231.htm#1290221 Filing: 000095017025044099 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 25.5 million Exact value Exact value: -25504000 USD 2024-01-01 – 2024-12-31: -25504000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2024-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -25504000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25504000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1362231 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	−USD 21.03 million Exact value Exact value: -21030000 USD 2024-01-01 – 2024-12-31: -21030000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2024-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -21030000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21030000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1414288 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	USD 19,000 Exact value Exact value: 19000 USD 2024-01-01 – 2024-12-31: 19000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2024-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 19000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1423598 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	−USD 21.05 million Calculation and evidence -21030000 − 19000 USD Exact free cash flow: -21049000 USD 2024-01-01 – 2024-12-31: -21030000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 19000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2024-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -21049000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21030000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1414288 Filing: 000119312526124396 Input fundies:CapitalExpenditure: 19000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1423598 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 34.8 million Exact value Exact value: -34800000 USD 2025-01-01 – 2025-12-31: -34800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Net Income: -34800000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1489938 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	−USD 29.8 million Exact value Exact value: -29800000 USD 2025-01-01 – 2025-12-31: -29800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Operating Cash Flow: -29800000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1490477 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	USD 23,000 Exact value Exact value: 23000 USD 2025-01-01 – 2025-12-31: 23000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Capital Expenditure: 23000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1421752 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.	−USD 29.82 million Calculation and evidence -29800000 − 23000 USD Exact free cash flow: -29823000 USD 2025-01-01 – 2025-12-31: -29800000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 23000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ATOSSA GENETICS INC · 2025-12-31 ATOSSA GENETICS INC (edgar:1488039) Free cash flow: -29823000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1488039?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1490477 Filing: 000119312526124396 Input fundies:CapitalExpenditure: 23000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm#1421752 Filing: 000119312526124396 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

88 filings · 3,532 latest values · 3,558 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001488039, 1488039, ATOS, atos, edgar:1488039

Also known as ATOSSA GENETICS INC, ATOSSA THERAPEUTICS, INC., Atossa Therapeutics, Inc.

ATOSSA GENETICS INC

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation